InvestorsHub Logo
Followers 7
Posts 496
Boards Moderated 0
Alias Born 11/15/2012

Re: trading.jeff post# 28130

Friday, 12/12/2014 9:30:15 PM

Friday, December 12, 2014 9:30:15 PM

Post# of 48316
That would translate to about $2.50/share at the high end.

But remember timing is everything. The earlier the buyout, the cheaper the buyout price because the buyer then starts to assume more of the risk. The longer big pharma waits, however, the higher the buyout price becomes. A classic case of weighing risk vs. reward.

IF a buyout were to occur by Merck, I'd suggest it "could" happen in Q3 or Q4 of 2015. Other suitors might be lining up in parallel, or afterwards.

But again, all of this is conjecture until proven as fact.